CR11741A - Antagonistas de la trayectoria hedgehog de ftalazina disustituida - Google Patents

Antagonistas de la trayectoria hedgehog de ftalazina disustituida

Info

Publication number
CR11741A
CR11741A CR11741A CR11741A CR11741A CR 11741 A CR11741 A CR 11741A CR 11741 A CR11741 A CR 11741A CR 11741 A CR11741 A CR 11741A CR 11741 A CR11741 A CR 11741A
Authority
CR
Costa Rica
Prior art keywords
antagonists
hedgehog
ftalazina
disttituted
trajectory
Prior art date
Application number
CR11741A
Other languages
English (en)
Inventor
Arthur Hipskind Philip
Wilson Takako
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CR11741A publication Critical patent/CR11741A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente invención se refiere a nuevos antagonistas de la trayectoria de hedgehog de ftalazina 1,4-disustituida, útiles en el tratamiento de cáncer.
CR11741A 2008-04-29 2010-10-15 Antagonistas de la trayectoria hedgehog de ftalazina disustituida CR11741A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4872908P 2008-04-29 2008-04-29

Publications (1)

Publication Number Publication Date
CR11741A true CR11741A (es) 2011-01-05

Family

ID=40846962

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11741A CR11741A (es) 2008-04-29 2010-10-15 Antagonistas de la trayectoria hedgehog de ftalazina disustituida

Country Status (22)

Country Link
US (1) US7981892B2 (es)
EP (1) EP2294061A2 (es)
JP (1) JP5442717B2 (es)
KR (1) KR101260116B1 (es)
CN (1) CN102066353B (es)
AU (1) AU2009241561B2 (es)
BR (1) BRPI0911618A2 (es)
CA (1) CA2723042A1 (es)
CO (1) CO6300945A2 (es)
CR (1) CR11741A (es)
DO (1) DOP2010000302A (es)
EA (1) EA201071248A1 (es)
EC (1) ECSP10010577A (es)
HN (1) HN2010002157A (es)
IL (1) IL208211A0 (es)
MA (1) MA32349B1 (es)
MX (1) MX2010011948A (es)
MY (1) MY159491A (es)
NZ (1) NZ588001A (es)
UA (1) UA102250C2 (es)
WO (1) WO2009134574A2 (es)
ZA (1) ZA201006695B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009241561B2 (en) 2008-04-29 2013-05-16 Eli Lilly And Company Disubstituted phthalazine hedgehog pathway antagonists
US8404687B2 (en) 2008-11-03 2013-03-26 Eli Lilly And Company Disubstituted phthalazine hedgehog pathway antagonists
KR101342184B1 (ko) 2008-11-17 2013-12-19 일라이 릴리 앤드 캄파니 사치환된 피리다진 헷지호그 경로 길항제
CA2743264C (en) * 2008-11-17 2014-02-18 Julia Marie Clay Tetrasubstituted pyridazines hedgehog pathway antagonists
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
EP2501370A1 (en) * 2009-11-18 2012-09-26 Novartis AG Methods and compositions for treating solid tumors and other malignancies
CN102702108A (zh) * 2012-06-27 2012-10-03 上海大学 1,2-二氢酞嗪类化合物及其合成方法
EP2895474B1 (en) * 2012-09-17 2019-12-11 Duke University Smoothened receptor modulators and methods of use thereof
CN102863393A (zh) * 2012-09-26 2013-01-09 上海大学 1,2-二氢酞嗪类化合物及其合成方法
GB201309508D0 (en) * 2013-05-28 2013-07-10 Redx Pharma Ltd Compounds
GB2528298A (en) * 2014-07-16 2016-01-20 Redx Pharma Plc Compounds
CN105985319B (zh) * 2015-02-11 2019-02-26 复旦大学 芳基酞嗪化合物及其制备方法和用途
CN105985320B (zh) * 2015-02-11 2018-10-26 复旦大学 苄基酞嗪化合物及其制备方法和用途
CN105985321B (zh) * 2015-02-11 2018-10-26 复旦大学 吡唑酞嗪化合物及其制备方法和用途
CN107163028B (zh) * 2017-05-24 2019-07-12 东南大学 一种苯甲酰胺类Hedgehog抑制剂及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293565A (en) 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
DK0876366T3 (da) 1996-01-15 2001-11-05 Janssen Pharmaceutica Nv Angiogenese-inhiberende pyridazinaminer
JP5067986B2 (ja) 1998-04-09 2012-11-07 ジョンズ ホプキンズ ユニヴァーシティー スクール オブ メディシン ヘッジホッグシグナリング経路の阻害剤としてのステロイドアルカロイド誘導体の使用
US6432970B2 (en) 1998-04-09 2002-08-13 Johns Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
WO2000074706A1 (en) 1999-06-08 2000-12-14 Lorantis Limited Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
WO2003088970A2 (en) 2002-04-22 2003-10-30 Johns Hopkins University School Of Medicine Modulators of hedgehog signaling pathways, compositions and uses related thereto
WO2004020599A2 (en) 2002-08-29 2004-03-11 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
US8067608B2 (en) * 2003-09-29 2011-11-29 The Johns Hopkins University Hedgehog pathway antagonists
TW200533356A (en) 2004-02-24 2005-10-16 Mitsubishi Pharma Corp Fused pyridazine derivatives
US8338591B2 (en) 2004-05-08 2012-12-25 Novartis International Pharmaceutical Ltd. 3-aryl-5,6-disubstituted pyridazines
UA96565C2 (ru) * 2004-09-02 2011-11-25 Дженентек, Инк. Пиридильные ингибиторы хеджхоговской передачи сигнала
EP1900731A1 (de) 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
MY156814A (en) 2007-03-15 2016-03-31 Novartis Ag Organic compounds and their uses
AU2008269128B2 (en) * 2007-06-25 2012-08-02 Amgen Inc. Phthalazine compounds, compositions and methods of use
EP2188283B1 (en) 2007-09-07 2012-08-15 Amgen Inc. Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
AU2009241561B2 (en) 2008-04-29 2013-05-16 Eli Lilly And Company Disubstituted phthalazine hedgehog pathway antagonists
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
US8404687B2 (en) 2008-11-03 2013-03-26 Eli Lilly And Company Disubstituted phthalazine hedgehog pathway antagonists
KR101342184B1 (ko) 2008-11-17 2013-12-19 일라이 릴리 앤드 캄파니 사치환된 피리다진 헷지호그 경로 길항제
CA2743264C (en) 2008-11-17 2014-02-18 Julia Marie Clay Tetrasubstituted pyridazines hedgehog pathway antagonists
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer

Also Published As

Publication number Publication date
MA32349B1 (fr) 2011-06-01
AU2009241561B2 (en) 2013-05-16
US20110046143A1 (en) 2011-02-24
JP5442717B2 (ja) 2014-03-12
ZA201006695B (en) 2012-09-26
CN102066353A (zh) 2011-05-18
WO2009134574A3 (en) 2014-09-04
ECSP10010577A (es) 2010-11-30
AU2009241561A1 (en) 2009-11-05
WO2009134574A2 (en) 2009-11-05
HN2010002157A (es) 2014-09-08
US7981892B2 (en) 2011-07-19
CA2723042A1 (en) 2009-11-05
UA102250C2 (ru) 2013-06-25
KR101260116B1 (ko) 2013-05-02
BRPI0911618A2 (pt) 2019-09-24
IL208211A0 (en) 2010-12-30
CN102066353B (zh) 2013-12-11
MX2010011948A (es) 2010-12-14
MY159491A (en) 2017-01-13
JP2011527666A (ja) 2011-11-04
CO6300945A2 (es) 2011-07-21
DOP2010000302A (es) 2010-11-15
EA201071248A1 (ru) 2011-06-30
KR20100126580A (ko) 2010-12-01
EP2294061A2 (en) 2011-03-16
NZ588001A (en) 2012-06-29

Similar Documents

Publication Publication Date Title
CR11741A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida
ECSP11011541A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida
ECSP11011021A (es) Antagonistas de la via hedgehog de ftalazina disustituida
EA200801758A1 (ru) Лекарственные формы, устойчивые к самовольному изменению
HN2011002809A (es) Compuestos de vinil indazolilo
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
CR20110046A (es) Amidofenoxiindazoles utiles como inhibidores de c-met
CL2010001474A1 (es) Compuestos derivados de tiofeno o tiazol sustituidos, inhibidores de pi3k; composicion farmaceutica; utiles en el tratamiento del cancer, inflamacion y en el tratamiento de trastornos cardiovasculares.
EA201001639A1 (ru) Композиции и способы их получения и применения
GT200900315A (es) Inhibición de arni de expresión de alfa-enac
IT1395519B1 (it) Pezzo composito, nonche' impiego del pezzo composito
CL2008000629A1 (es) Compuestos macrociclicos derivados de 6-aril-4-mercapto-[1.3.5]triazina/[1.3]pirimidin-2-amina; composicion farmaceutica, utiles en el tratamiento del cancer.
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
CR20110552A (es) Tratamiento de transtornos resistentes a la insulina
BRPI0807804A2 (pt) " arilciclopentenos substituídos como agentes terapêuticos ".
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
DK2081944T3 (da) Nye morfin-derivater
BRPI1014211A2 (pt) "composição."
FR2911479B1 (fr) Ensemble de vetements.
CY1114078T1 (el) Ανταγωνιστες διυποκατεστημενης φθαλαζινης του μονοπατιου hedgehog
IT1401957B1 (it) Composizione per il trattamento dell'acne.
UA36741U (ru) 1-фенил-4-о-толиламино-1,5-дигидропиррол-2-он, который проявляет анальгетическую и противовоспалительную активность